Venture Planning Group

This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

This new report from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: ...

... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. 'Competing in the Global Therapeutic Drug Monitoring (TDM) Market' is a unique worldwide market and technology assessment designed to help current suppliers and ...

... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. 'Competing in the Global Endocrine Function Diagnostics Market' is a unique worldwide market and technology assessment designed to help current suppliers and potential ...

This new report from Venture Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood ...

... . Feature comparison of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, ...

This new 275-page report from Venture Planning Group contains 42 tables, and presents a comprehensive analysis of the US hematology and flow cytometry markets, including: Major issues pertaining to the US hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and ...

... . Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

... , marketing tactics, collaborative arrangements and new technologies/products in R&D. Comprehensive listings of companies developing and marketing molecular diagnostics products, by test and application. Opportunities and Strategic Recommendations Specific new product development opportunities with ...

... testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, continuing contraction ...